Literature DB >> 23971850

Risk factors associated with survival in dogs with nontonsillar oral squamous cell carcinoma 31 cases (1990-2010).

Amy J Fulton1, Ana Nemec, Brian G Murphy, Philip H Kass, Frank J M Verstraete.   

Abstract

OBJECTIVE: To identify risk factors associated with survival in dogs with nontonsillar oral squamous cell carcinoma (OSCC) that were and were not treated with curative-intent surgery.
DESIGN: Retrospective case series. ANIMALS: 31 dogs with OSCC. PROCEDURES: Medical records for dogs with OSCC that were not treated, or were treated with curative-intent surgery only between January 1990 and December 2010 were reviewed. For each dog, data regarding signalment, clinical stage, treatment, tumor recurrence, and survival time were obtained from the medical record, and archived biopsy specimens were evaluated to identify the histologic subtype of the tumor and extent of tumor-associated inflammation (TAI), perineural invasion (PNI), and lymphovascular invasion (LVI).
RESULTS: Risk of death for the 21 dogs with OSCC that were surgically treated was decreased 91.4% (hazard ratio, 0.086; 95% confidence interval, 0.002 to 0.150), compared with that for the 10 dogs with OSCC that were not treated. The 1-year survival rate was 93.5% and 0% for dogs that were and were not surgically treated, respectively. Risk of death increased significantly with increasing TAI and increasing risk score (combination of TAI, PNI, and LVI). Tumor location, clinical stage, and histologic subtype were not associated with survival time. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that the prognosis for dogs with OSCC was excellent following surgical excision of the tumor. Risk of death increased with increasing TAI, and combining TAI, PNI, and LVI into a single risk score may be a useful prognostic indicator for dogs with OSCC.

Entities:  

Mesh:

Year:  2013        PMID: 23971850     DOI: 10.2460/javma.243.5.696

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  9 in total

1.  Occult tonsillar squamous cell carcinoma in 2 dogs presenting for treatment of primary oral squamous cell carcinoma.

Authors:  Nicholas J Rancilio; Christopher M Fulkerson
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia.

Authors:  Valeria Meier; Franco Guscetti; Malgorzata Roos; Stefanie Ohlerth; Martin Pruschy; Carla Rohrer Bley
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

Review 3.  Non-murine models to investigate tumor-immune interactions in head and neck cancer.

Authors:  Carlos Rossa; Nisha J D'Silva
Journal:  Oncogene       Date:  2019-03-14       Impact factor: 9.867

4.  Extended Subtotal Mandibulectomy for the Treatment of Oral Tumors Invading the Mandibular Canal in Dogs-A Novel Surgical Technique.

Authors:  Nadine Fiani; Santiago Peralta
Journal:  Front Vet Sci       Date:  2019-10-04

5.  Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs.

Authors:  Nina Milevoj; Ana Nemec; Nataša Tozon
Journal:  Front Vet Sci       Date:  2022-03-31

6.  p-S6 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma.

Authors:  Leonor Delgado; Paula Brilhante-Simões; Fernanda Garcez; Luís Monteiro; Isabel Pires; Justina Prada
Journal:  Biomolecules       Date:  2022-07-04

Review 7.  Locoregional Flap Reconstruction Following Oromaxillofacial Oncologic Surgery in Dogs and Cats: A Review and Decisional Algorithm.

Authors:  Michel Guzu; Diego Rossetti; Philippe R Hennet
Journal:  Front Vet Sci       Date:  2021-05-21

8.  Osteonecrosis of the Jaws in Dogs in Previously Irradiated Fields: 13 Cases (1989-2014).

Authors:  Ana Nemec; Boaz Arzi; Katherine Hansen; Brian G Murphy; Milinda J Lommer; Santiago Peralta; Frank J M Verstraete
Journal:  Front Vet Sci       Date:  2015-04-01

Review 9.  Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.

Authors:  Qiang Li; Heng Dong; Guangwen Yang; Yuxian Song; Yongbin Mou; Yanhong Ni
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.